IDV vehicle
36E79725D0031
NEW AWARD FOR HUMAN INSULIN WITH SANOFI-AVENTIS US LLC. ORDERING PERIOD IS JULY 1, 2025 TO JUNE 30, 2026 WITH FOUR ONE-YEAR OPTIONS"
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $465.4M |
| Start date | Jul 1, 2025 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | May 5, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 5, 2026 | P00003 | $0 | EXERCISE THE FIRST OPTION YEAR FOR HUMAN INSULIN CONTRACT 36E79725D0031 WITH SANOFI-AVENTIS US LLC |
| Dec 12, 2025 | P00002 | $0 | INCORPORATE SANOFI AVENTIS US LLC 2026 SUBCONTRACTING PLAN |
| Nov 20, 2025 | P00001 | $0 | ACKNOWLEDGE 2026 FEDERAL CEILING PRICE. NO CHANGE IN NATIONAL CONTRACT PRICE. |
| May 8, 2025 | 0 | $0 | NEW AWARD FOR HUMAN INSULIN WITH SANOFI-AVENTIS US LLC. ORDERING PERIOD IS JULY 1, 2025 TO JUNE 30, 2026 WITH FOUR ONE-YEAR OPTIONS" |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.